Ramzi Khamis: Higher Levels of Natural Antibodies Against Malondialdehyde-Modified LDL
Ramzi Khamis, The Wu Family Endowed Chair of Cardiology at the National Heart and Lung Institute, posted on LinkedIn:
“Delighted to share our new publication.
This study extends the paradigm that immune responses to oxidised lipoproteins influence not only atherosclerosis, but also the biology of valvular calcification. Higher levels of natural antibodies against malondialdehyde-modified LDL (MDA-LDL), particularly IgM, were associated with less aortic and mitral valve calcification on CT imaging.
These findings lend further weight to the concept that the immune system’s recognition of oxidised lipid epitopes may confer a degree of vascular protection , an area that continues to bridge vascular immunology, lipid oxidation, and imaging science.
Congratulations to Adam Hartley and the team. We are so greatful to the outstanding SCOT-HEART team, whose meticulous imaging phenotyping and translational curiosity made this work possible. A wonderful example of how population imaging and molecular immunology can converge to illuminate new dimensions of cardiovascular disease. Kudos to Michelle Williams, David Newby and the team who made this possible.”
Title: Anti‐Malondialdehyde Low‐Density Lipoprotein Antibodies and Valvular Calcification: A Substudy of the SCOT‐HEART Trial
Authors: Adam Hartley, Michelle C. Williams, Amit Kaura, Sarah Verhemel, Mikhail Caga-Anan, Damini Dey, Marc R. Dweck, Dorian O. Haskard, Michael Joner, Manuel Mayr, David E. Newby, Ramzi Y. Khamis

Read full paper here.
Stay informed with Hemostasis Today.
-
Sep 23, 2026, 06:24Nicolas Gendron: Everolimus and Venous Thromboembolic Risk in Kidney Transplantation
-
Sep 23, 2026, 06:07Hoori Shahwar: Cerebral Venous Sinus Thrombosis Diagnosis and Management
-
Sep 23, 2026, 06:06Advancing Hemophilia Care and Patient Advocacy in Bangladesh – World Federation of Hemophilia
-
Sep 23, 2026, 05:54Bringing the Global Thrombosis and Haemostasis Community Together in 2027 – ISTH
-
Sep 23, 2026, 04:34David Akande: When Sickle Cell Crises Have No Clear Trigger
-
Sep 23, 2026, 04:13Jean Connors: Safety of Heparin Re-Exposure in Patients with Remote HIT
-
Sep 23, 2026, 04:09Beth Psaila: Applications Now Open for the Gordon Research Conference on Megakaryocytes and Platelets
-
Sep 23, 2026, 03:27Abbie Newton: How Better Data Can Reduce Platelet Wastage
-
Sep 23, 2026, 03:01Suvro Sankha Datta: Rapid Blood Group Genotyping Using Gold Oligo Nanonet Assembly